TickerLeague

Buyback Spend for Cencora (COR)

Buyback Spend for Cencora (COR): headline value $50.00M · YoY -70.8%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$50.00M

YoY change

-70.8%

5Y CAGR

+0.7%

Peak year (2016)

$2.27B

Latest annual

$435.47M

Buyback Spend history chart for Cencora (COR) from 1994 to 2025

Buyback Spend history table for Cencora (COR) from 1994 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$435.47M-70.8%
2024$1.49B+26.3%
2023$1.18B+144.1%
2022$483.70M+488.8%
2021$82.15M-80.5%
2020$420.45M-37.6%
2019$674.03M+5.4%
2018$639.24M+93.7%
2017$329.93M-85.4%
2016$2.27B+11.1%
2015$2.04B+170.5%
2014$753.93M+55.7%
2013$484.18M-58.3%
2012$1.16B+38.3%
2011$840.58M+78.7%
2010$470.36M+4.4%
2009$450.35M-33.8%
2008$680.62M-52.6%
2007$1.44B+99.7%
2006$719.25M-8.7%
2005$787.76M+440.7%
2004$145.69M
2003$0
2002$0
2001$0
2000$0-100.0%
1999$400,000
1998$0
1997$0
1996$0-100.0%
1995$5.70M
1994$0

Buyback Spend values are taken from Cencora's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

Cencora (COR) most recent annual buyback spend stands at $435.47M (2025) – plunged 70.8% year-over-year.

Through 2020–2025 (5 years), Cencora buyback spend delivered a +0.7% annualised rate; with the latest reading among the more recent periods of the dataset.

Cencora buyback spend peaked at $2.27B in 2016; the latest annual figure is $435.47M in 2025 (80.8% below peak).

The dataset's maximum buyback spend sits at $2.27B (2016); the minimum reading of $0 dates to 1994.

Within Healthcare, Cencora (COR) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.

Cencora Buyback Spend by Year

Cencora Buyback Spend 2025: $435.47M

Cencora buyback spend in 2025 was $435.47M, plunged 70.8% below 2024.

Cencora Buyback Spend 2024: $1.49B

Cencora buyback spend in 2024 was $1.49B, grew 26.3% from 2023.

Cencora Buyback Spend 2023: $1.18B

Cencora buyback spend in 2023 was $1.18B, surged 144.1% from 2022.

Cencora Buyback Spend 2022: $483.70M

Cencora buyback spend in 2022 was $483.70M, surged 488.8% from 2021.

Cencora Buyback Spend 2021: $82.15M

Cencora buyback spend in 2021 was $82.15M.

See more financial history for Cencora (COR).

Sector peers — Buyback Spend

Companies in the same sector as Cencora, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is Cencora's buyback spend?

Latest reported buyback spend for Cencora (COR) is $50.00M (period ending December 31, 2025).

How has Cencora buyback spend changed year-over-year?

Cencora (COR) buyback spend changed -70.8% year-over-year on the latest annual filing.

What is the long-term growth rate of Cencora buyback spend?

Cencora (COR) buyback spend compound annual growth rate is +0.7% over the most recent 5 years available.

When did Cencora buyback spend hit its highest annual value?

Cencora buyback spend reached its highest annual value of $2.27B in 2016.

What was Cencora buyback spend in 2024?

Cencora (COR) buyback spend in 2024 was $1.49B.

What was Cencora buyback spend in 2025?

Cencora (COR) buyback spend in 2025 was $435.47M.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.